Clinical Trial Results: Positive data often drives the stock price up, while negative data can cause it to plummet.

Regulatory Approvals: FDA approval for IROH.US's drugs will likely increase the stock price; rejection will have the opposite effect.

Market Conditions: General market sentiment and economic factors can influence investor confidence and impact IROH.US's stock price.

Competition: The success or failure of competing drugs can impact IROH.US's market share and stock value.

Financial Performance: Strong revenue growth and profitability typically lead to a higher stock price, while losses can decrease it.

Partnerships and Acquisitions: Strategic alliances or acquisitions can signal growth potential and boost the stock price.

News and Events: Major announcements, press releases, and industry events can influence investor perception and trading activity.

Analyst Ratings: Upgrades from financial analysts often lead to increased buying pressure and a higher stock price.

Drug Pricing and Reimbursement: Decisions on drug pricing and insurance coverage can affect IROH.US's revenue and stock performance.